Response predictors to treatment with pegylated interferon in chronic hepatitis B

Response predictors to treatment with pegylated interferon in chronic hepatitis B

Autor Ferreira, Paulo Roberto Abrão Autor UNIFESP Google Scholar
Tenore, Simone de Barros Autor UNIFESP Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
CRT STD-Aids Viral Hepatitis Group
Resumo The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease have been studied, both before and during the course of medication. Therapy stopping rules have been proposed, which may be useful in patients presenting poor treatment tolerance. This review discusses the treatment response predictors usefulness, with emphasis on ALT, quantitative HBsAg and HBeAg, quantitative HBV-DNA and HBV genotype
Assunto hepatitis B
HBsAg
HBeAg
HBV-DNA
pegylated interferon
Idioma Inglês
Financiador MSD
ROCHE
BMS
Janssen
Data 2010-10-01
Publicado em Brazilian Journal of Infectious Diseases. Brazilian Society of Infectious Diseases, v. 14, n. 5, p. 519-525, 2010.
ISSN 1413-8670 (Sherpa/Romeo, fator de impacto)
Editor Brazilian Society of Infectious Diseases
Extensão 519-525
Fonte http://dx.doi.org/10.1590/S1413-86702010000500017
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000286107300017
SciELO S1413-86702010000500017 (estatísticas na SciELO)
URI http://repositorio.unifesp.br/handle/11600/5959

Mostrar registro completo




Arquivos deste item

Nome: S1413-86702010000500017.pdf
Tamanho: 1.048Mb
Formato: PDF
Descrição:
Visualizar/Abrir

Este item aparece na(s) seguinte(s) coleção(s)